Oleksandr Dudnichenko

1PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 17, 2025
KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy.

Hope S Rugo, David W Cescon, Mark E Robson

Pageof 1

Frequent Collaborators

1 joint publications

Hope S Rugo

1 joint publications

David W Cescon

1 joint publications

Mark E Robson

1 joint publications

Seock-Ah Im